Jed Black

jazz pharmaceuticals

H指数:42

被引数:6,983

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prevalence of diagnosed idiopathic hypersomnia among adults in the United States 2019-2023: analysis of healthcare claims

2019-2023年美国成人中诊断的原发性嗜睡患病率：医疗索赔分析

SLEEP Advances

IF0

2026-01-010

PRE

Effects of oxybate dose and regimen on disrupted nighttime sleep and sleep architecture: A Plain Language Summary

纳洛酮剂量和给药方案对夜间睡眠中断及睡眠结构的影响：简明语言摘要

Future Neurology

IF0.5

2025-12-310

PRE

Effects of Low-Sodium Oxybate on Diary-Based Sleep Time in a Clinical Study in Adults With Idiopathic Hypersomnia

低钠氧基酸盐对成人特发性嗜睡症临床研究中基于日记的睡眠时间的影响

Sleep Medicine

IF3.4

2025-12-080

PRE

The Clinical and Economic Burden of Idiopathic Hypersomnia and Narcolepsy: A United States Claims-Based Analysis

特发性嗜睡和发作性睡病的临床与经济负担：一项基于美国索赔数据的分析

Nature and Science of Sleep

IF3.4

2025-08-080

The Clinical and Economic Burden of Idiopathic Hypersomnia: Results from the Real-World Idiopathic Hypersomnia Total Health Model (RHYTHM) Study

特发性嗜睡的临床和经济负担：来自真实世界特发性嗜睡整体健康模型（RHYTHM）研究的结果

Nature and Science of Sleep

IF3.4

2025-07-300

Cardiovascular burden of individuals diagnosed with idiopathic hypersomnia: Real-World Idiopathic Hypersomnia Total Health Model (CV-RHYTHM)

特发性嗜睡症患者的心血管负担：真实世界特发性嗜睡症总体健康模型（CV-RHYTHM）

Sleep Medicine

IF3.4

2025-05-190

Increased Risk of New-Onset Hypertension in Patients With Narcolepsy Initiating Sodium Oxybate: A Real-World Study

起始羟丁酸钠的发作性睡病患者新发高血压的风险增加: 一项真实世界研究

MAYO CLINIC PROCEEDINGS

IF6.7

2024-11-011

OAAI

Rethinking clinical trials in restless legs syndrome: A roadmap

SLEEP MEDICINE REVIEWS

IF9.7

2024-10-011

PRE

Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients with Narcolepsy: A Commentary (vol 12, pg 1805, 2023)

NEUROLOGY AND THERAPY

IF4.8

2024-06-240

OAAI

Response to Letter to the Editor Regarding Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients With Narcolepsy: A Commentary

NEUROLOGY AND THERAPY

IF4.8

2024-05-250

OAAI

Effect of sodium oxybate on body mass index in pediatric patients with narcolepsy

JOURNAL OF CLINICAL SLEEP MEDICINE

IF2.9

2024-03-012

PRE

Effects of oxybate dose and regimen on disrupted nighttime sleep and sleep architecture

SLEEP MEDICINE

IF3.4

2024-02-015

OAAI

Long-term efficacy and safety of low-sodium oxybate in an open-label extension period of a placebo-controlled, double-blind, randomized withdrawal study in adults with idiopathic hypersomnia

JOURNAL OF CLINICAL SLEEP MEDICINE

IF2.9

2023-10-016

PRE

Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients with Narcolepsy: A Commentary

NEUROLOGY AND THERAPY

IF4.8

2023-09-276

OAAI

Cardiovascular Burden of Narcolepsy Disease (CV-BOND): a real-world evidence study

SLEEP

IF4.9

2023-06-1220

OAAI

Efficacy and Safety of Lower-Sodium Oxybate in an Open-Label Titration Period of a Phase 3 Clinical Study in Adults with Idiopathic Hypersomnia

低羟丁酸钠在成人特发性睡眠过度的3期临床研究的开放标签滴定期的疗效和安全性

NATURE AND SCIENCE OF SLEEP

IF3.4

2022-10-019

OAAI

Long-term safety and maintenance of efficacy of sodium oxybate in the treatment of narcolepsy with cataplexy in pediatric patients

JOURNAL OF CLINICAL SLEEP MEDICINE

IF2.9

2022-09-0110

Changes in Cataplexy Frequency in a Clinical Trial of Lower-Sodium Oxybate with Taper and Discontinuation of Other Anticataplectic Medications (vol 36, pg 633, 2022)

CNS DRUGS

IF7.4

2022-06-280

OAAI

Changes in Cataplexy Frequency in a Clinical Trial of Lower-Sodium Oxybate with Taper and Discontinuation of Other Anticataplectic Medications

CNS DRUGS

IF7.4

2022-05-3012

OAAI

Validation of the Epworth Sleepiness Scale for Children and Adolescents (ESS-CHAD) questionnaire in pediatric patients with narcolepsy with cataplexy aged 7-16 years

SLEEP MEDICINE

IF3.4

2022-01-0118

OAAI

Jed Black

个人简介

教育背景

工作经历

荣誉奖项

研究方向